Protective role of heme oxygenase-1 against inflammation in atherosclerosis

Frontiers in Bioscience

Volumn 16, Issue 6, 2011, Pages 2372-2388

  Durante, William ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Adaptive immunity; Atherosclerosis; Bilirubin; Biliverdin; Carbon monoxide; Heme; Heme oxygenase 1; Immune cells; Inflammation; Innate immunity; Review

Indexed keywords

AUTACOID; CYTOKINE; HEME; HEME OXYGENASE 1;

ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; MOUSE MUTANT; REVIEW;

ANIMALS; ATHEROSCLEROSIS; CYTOKINES; HEME; HEME OXYGENASE-1; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL;

EID: 79959702836     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3860     Document Type: Review

References (158)

1. Faxon, D.P., V. Fuster, P. Libby, J.A. Beckman, W.R. Hiatt, R.W. Thompson, J.N. Topper, B.H. Annex, J.H. Rundback, R.P. Fabunmi, R.M. Robertson and J. Loscalzo; American Heart Association: Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 109, 2617-2625 (2004) (Pubitemid 38720566)
2. Rosamond, W., K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S.M. Hailpern, M. Ho M, V. Howard, B. Kissela, S. Kittner, D. Lloyd-Jones, M. McDermott, J. Meigs, C. Moy, G. Nichol, C. O'Donnell, V. Roger, P. Sorlie, J. Steinberger, T. Thom, M. Wilson and Y. Hong; American Heart Association: Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146 (2008)
3. Olshansky, S.J., D.J. Passaro, R.C. Hershow, J. Layden, B.A Carnes, J. Brody, L. Hayflick, R.N. Butler, D.B. Allison and D.S. Ludwig: A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352, 1138-1145 (2005) (Pubitemid 40365358)
4. Libby. P., P.M. Ridker and G.K. Hansson for the Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54, 2129-2138 (2009)
5. Hansson, G.K. and P. Libby: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508-519 (2006) (Pubitemid 43980523)
6. Rocha, V.Z. and P. Libby: Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6, 399-409 (2009)
7. Tenhunen, R., H.S. Marver and R. Schmid: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61, 748-755 (1968)
8. Maines, M.D: Heme oxygenase: functions, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2, 2557-2568 (1989)
9. Durante, W., F.K. Johnson and R. A. Johnson: Role of carbon monoxide in cardiovascular function. J Cell Mol Med 10, 672-686 (2006) (Pubitemid 44874276)
10. Abraham, N.G. and A. Kappas: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60, 79-127 (2008) (Pubitemid 351439218)
11. Ryter, S.W., J. Alam and A.M.K. Choi: Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86, 583-650 (2006)
12. Wagener, F.A.D.T.G., H.-D.Volk, D. Willis, N.G Abraham, M.P. Soares, G,J. Adema and C.G. Figdor: Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55, 551-571 (2003) (Pubitemid 37013215)
13. Willis, D., A.R. Moore, R. Frederick and D.A. Willoughby: Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2, 87-90 (1996) (Pubitemid 26029572)
14. Tamion, F., V. Richard, S. Renet and C. Thuillez. Protective effects of heme oxygenase-1 expression against endotoxin shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10. J Trauma 61, 1078-1084 (2006) (Pubitemid 44737010)
15. Minamino, T., H. Christou, C.M. Hsieh, Y. Liu, V. Dhawan, N.G. Abraham, M.A. Perrella, S.A. Mitsialis and S. Kourembanas: Targeted expression of heme oxygenase- 1 prevents the pulmonary inflammatory and vascular response to hypoxia. Proc Natl Acad Sci USA 98, 8793-8803 (2001).
16. Agarwal, A and H.S. Nick: Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 11, 965-973 (2001) (Pubitemid 30241733)
17. Nath, K.A., Vercellotti G.M., J.P. Grande, H. Miyoshi, C.V. Paya, J.C. Manivel, J.J. Haggard, A.J. Croatt, W.D. Payne and J. Alam: Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 59, 106-117, (2001) (Pubitemid 32055219)
18. Otterbein, L.E., J.K. Kolls, L.L. Mantell, J.L. Cook, J. Alam and A.M. Choi: Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103, 1047-1054 (1999) (Pubitemid 29169613)
19. Wunder C. and R.F. Potter: The heme oxygenase system: its role in liver inflammation. Curr Drug Targets Cardiovasc Haematol Disord 3, 199-208, (2003) (Pubitemid 37021235)
20. Soares, M.P., Y. Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S.T. Grey, R.B. Colvin, A.M. Choi, K.D. Poss and F.H. Bach: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4, 1073-1077 (1998) (Pubitemid 28417343)
21. Soares, M.P. and F.H. Bach: Heme oxygenase-1 in organ transplantation. Front Biosci 12, 4932-4945 (2007)
22. Nakao, A., A.M.K. Choi and N. Murase: Protective effect of carbon monoxide in transplantation. J Cell Mol Med 10, 650-671 (2006) (Pubitemid 44874275)
23. Hancock, W.W., R. Buelow, M.H. Sayegh and L.A. Turka: Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and antiapoptotic genes. Nat Med 4, 1392-1396 (1998) (Pubitemid 28553461)
24. Poss, K.D. and S. Tonegawa: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94, 10925-10930 (1997) (Pubitemid 27430837)
25. Poss, K.D. and S.Tonegawa: Heme oxygenase-1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94, 10919-10924 (1997) (Pubitemid 27430836)
26. Kapturczak, M.H., C. Wasserfall, T. Brusko, M. Campell-Thompson, T.M. Ellis, M.A. Atkinson and A. Agarwal: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165, 1045-1053 (2004) (Pubitemid 39129309)
27. Yachie, A., Y. Niida, T. Wada, N. Igarashi, H. Kaneda, T. Toma, K. Ohta, Y. Kasahara and S. Koizumi: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103, 129-135 (1999) (Pubitemid 29031171)
28. Kawashima, A., T. Oda, A. Yachie, S. Koizumi and I. Nakanishi: Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33, 125-130 (2002) (Pubitemid 34112962)
29. Madhavan, M., W.A. Wattigney, S.R. Srinivasan and G.S. Berenson: Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 131, 107-113 (1997) (Pubitemid 27240103)
30. Caliskan, M., D. Erdogan, H. Gullu, D. Tok, M. Bilgi and H. Muderrisoglu: Low serum bilirubin concentrations are associated with impaired aortic elastic properties, but not impaired left ventricular diastolic function. Int J Clin Pract 61, 218-224 (2007)
31. Graca-Souza, A.V., M.A. Arruda, M.S. de Freitas, C. Barja-Fidalgo and P.L. Oliveira: Neutrophil activation by heme: implications for inflammatory processes. Blood 99, 4160-4165 (2002) (Pubitemid 35332061)
32. Figueiredo, R.T., P.L. Fernandez, D.S. Mourao-Sa, B.N. Porto,F.F. Dutra, L.S. Alves, M.F. Oliveira, A.V. Graca-Souza and M.T. Bozza: Characterization of heme as an activator of Toll-like receptor 4. J Biol Chem 282, 20221-20229 (2007) (Pubitemid 47100035)
33. Wagener, F.A.D.T.G., J.L. da Silva, T. Farley, T de Witte, A. Kappas and N.G. Abraham: Differential effects of heme oxygenase isoforms on heme mediated endothelial ICAM-1 expression. J Pharmacol Exp Ther 291, 416-423 (1999) (Pubitemid 29451618)
34. Wagener, F.A.D.T.G., A. Eggert, O. C. Boerman, W.J. Oyen, A. Verhofstad, N.G. Abraham, G. Adema, Y. van Kooyk, T. de Witte and C.G. Figdor: Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98, 1802-1811 (2001)
35. Alcaraz, M.J., P. Fernandez and M.I. Guillen: Antiinflammatory actions of the heme oxygenase pathway. Curr Drug Des 9, 2541-2551 (2003) (Pubitemid 37236372)
36. Pae, H.-O., Y.C. Lee and H.-T. Chung: Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Patents Inflammation Allergy Drug Discovery 2, 159-165 (2008)
37. Soares, M.P., I. Marguti, A. Cunha and R. Larsen: Immunoregulatory effects of HO-1: how does it work? Curr Opin Pharmacol 9, 482-489 (2009)
38. Wang, L.J., T.S. Lee, F.Y. Lee, R.C. Pai and L.Y. Chau: Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152, 711-720 (1998)
39. Nakayama, M., K. Takahashi, T. Komaru, M. Fukuchi, H. Shioiri, K. Sato, T. Kitaura, K. Shirato, T. Yamaguchi, M. Suematsu and S. Shibahara: Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21, 1373-1377 (2001) (Pubitemid 34219847)
40. Cheng, C., A.M. Noordeloos, V. Jeney, M.P. Soares, F. Moll, G. Pasterkamp, P.W. Serruys and H.J. Duckers: Heme oxygenase-1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119, 3017-3027 (2009)
41. Li, Y.G., D.M. Wang, S.M. Chen, X.R. Tan, X.Y. Fang, J.W. Wu, G.H Zhang and R.Q. Mai: Haem oxygenase-1 expression and coronary heart disease-association between levels of haem oxygenase-1 expression and angiographic morphology as well as the quantity of coronary lesions. Acta Cardiol 61, 295-300 (2006)
42. Ameriso, S.F., A.R. Villamil, C. Zedda, J.C. Parodi, S. Garrido, M.I. Sarchi, M. Shultz, J. Bocskowski and G.E Sevlever: Heme oxygenase-1 is expressed in carotid atherosclerotic plaque infected by Helicobacter pylori and is more prevalent in asymptomatic patients. Stroke 36, 1896-1890 (2005)
43. Chen, Y.H., S.Y. Lin, M.W. Lin, H.L. Tsai, S.S. Kuo, J.W. Chen, M.J. Chang, T.C. Wu, L.C. Chen, Y.A. Ding, W.H. Pan, Y.S. Jou and L.Y Chau: Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type II diabetic patients. Hum Genet 111, 1-8 (2002)
44. Kaneda, H., M. Ohno, J. Taguchi, H. Hashimoto, T. Ogasawura, T. Aizawa, N. Ishizaka and R. Nagai: Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22, 1680-1685 (2002)
45. Endler, G., M. Exner, M. Schillinger, R. Marculescu, R. Sunder-Plassmann, M. Raith, N. Jordanova, J. Wojita, C. Mannhalter, O.F. Wagner and K. Huber: A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemostasis 91, 155-161 (2004) (Pubitemid 38111232)
46. Ishikawa, K., D. Sugawara, J. Goto, K. Watanabe, S. Kawamura, M. Shiomi, H. Itabe and Y. Maruyama: Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104, 1831-1836 (2001) (Pubitemid 32963350)
47. Ishikawa, K., D. Sugawara, X.P. Wang, K. Suzuki, H. Itabe, Y. Maruyama Y and A.J. Lusis: Heme oxygenase-1 inhibits atherosclerosis lesion formation in ldl-receptor knockout mice. Circ Res 88, 506-512 (2001) (Pubitemid 32240914)
48. Yet, S.F., M.D. Layne, X. Liu, Y.H. Chen, B. Ith, N.E. Sibing and M.A. Perrella: Absence of heme oxygenase-1 exacerbates atherosclerosis lesion formation and vascular remodeling. FASEB J 17, 1759-1761 (2003)
49. Juan, S.H., T.S. Lee, K.W. Tseng, J.Y. Liou, S.K. Shyue, K.K.Wu and L.Y. Chau: Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein Edeficient mice. Circulation 104, 1519-1525 (2001) (Pubitemid 32917345)
50. Bouche, D., B.D. Chauveau, J.C. Roussel, P. Mathieu, C. Bradeau, L. Tesson, J.P. Soulillou, S. Iyer, R. Buelow and I. Anegon: Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 9, 235-238 (2002) (Pubitemid 34863390)
51. Du, D., S. Chang, B. Chen, H. Zhou and Z.K. Chen: Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants. Transpl Proc 39, 3446-3448 (2007) (Pubitemid 350251447)
52. Tsui, T.Y., X. Wu, C.K. Lau, D.W. Ho, T. Xu, Y.T. Siu and S.T. Fan: Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 107, 2623-2629 (2003) (Pubitemid 36628946)
53. Stocker, R., Y. Yamamoto, A.F. McDonagh, A.N. Glazer and B.N. Ames: Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046 (1987) (Pubitemid 17049750)
54. Neuzil, J and R. Stocker: Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem 269, 16712-16719 (1994)
55. Ferris, C.D., S.R. Jaffrey, A. Sawa, M. Takahashi, S.D. Brady, R. K. Barrow, S.A. Tysoe, H. Wolosker, D.E. Baranano, S. Dore, K.D. Poss and S.H. Snyder: Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1: 152-157 (1999) (Pubitemid 129656019)
56. Piantadosi,C.A., M.S. Carraway and H.B. Suliman: Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radic Biol Med 40, 1332-1339 (2006)
57. Taille, C., J. El-Benna, S. Lanone, J. Boczkowski and R. Motterlini: Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280, 25350-25360 (2005) (Pubitemid 40962237)
58. Soares, M.P., M.P. Seldon, I.P. Gregoire, T. Vassilevskaia, P.O. Berberat, J. Yu, T.-Y. Tsui and F.H. Bach: Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial activation. J Immunol 172, 3553-3563 (2004) (Pubitemid 38337936)
59. Lin, C.C., X.M. Liu, K.J. Peyton, H. Wang, W.C. Wang, S.J. Lin and Durante W: Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 28, 739-745 (2008) (Pubitemid 351651343)
60. Pae, H.O., G.S. Oh, B.S. Lee, J.S. Rim, Y.M. Kim and H.T. Chung: 3-Hydorxyanthranilic acid, one of Ltryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 187, 274-284 (2006)
61. Vachharajan, T.J., J. Work, A.C. Issekutz and D.N. Granger: Heme oxygenase modulates selectin expression in different vascular beds. Am J Physiol Heart Circ Physiol 278, H1613-H1617 (2000) (Pubitemid 30395574)
62. Mazzone, G.L., I. Rigato, J.D. Ostrow and C.Tiribelli: Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-kappaB signaling pathway. Biosci Trends 3, 151-157 (2009)
63. Morita, T., T. Imai, T. Yamaguchi, T. Sugiyama, S. Katayama and G. Yoshino: Induction of heme oxygenase- 1 suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme. Antioxid Redox Signal 5, 439-447 (2003) (Pubitemid 37087404)
64. Orozco, L.D., M.H. Kapturczak, B. Barajas, X. Wang, M.M. Weinstein, J. Wong, J. Deshane, S. Bolisetty, Z. Shaposhnik, D. Shih, A. Agarwal, A.J. Lusis and J.A. Araujo: Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100: 1703-1711 (2007) (Pubitemid 46987862)
65. Sawle, P., R. Foresti, B.E. Mann, T.R. Johnson, C.J. Green and R. Motterlini: Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145, 800-810 (2005) (Pubitemid 41076287)
66. Otterbein, L.E., F.H. Bach, J. Alam, M.P. Soares, H. Tao Lu, M. Wysk, R.J. Davis, R.A. Flavell and A.M. Choi: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6, 422-428 (2000) (Pubitemid 30208159)
67. Wang X.M., H.P. Kim, K. Nakahira, S.W. Ryter and A.M.K. Choi: The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182, 3809-3818 (2009)
68. Sarady, J.K., S.L. Otterbein, F Liu., L.E. Otterbein and A.M.K. Choi: Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 27, 739-745 (2002) (Pubitemid 35381183)
69. Weis, N., A. Weigert, A. von Knethen and B. Brune: Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 20, 1280-1288 (2009)
70. Wegiel, B., C.J. Baty, D. Gallo, E. Csizmadia, J.R. Scott, A. Akhaven, B.Y Chin, E. Kaczmarek, J. Alam, F. H. Bach, B.S. Zuckerbraun and L.E. Otterbein: Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol-3- kinase and Akt. J Biol Chem 284, 21369-21378 (2009)
71. Moore, K.W., R. de Waal Malefyt, R.L. Coffman and A. O'Garra: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765 (1989)
72. Lee, T.-S. and L.-Y. Chau: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8, 240-246 (2002) (Pubitemid 34250101)
73. Chen, S., M. H. Kapturczak, C. Wasserfall, O.Y. Glushakova, M. Campbell-Thompson, J.S. DeShane, R. Joseph, P.E. Cruz, W.W. Hauswirth, K.M. Madsen, B.P Croker, K.I. Berns, M.A. Atkinson, T.R. Flotte, C.C. Tisher and A. Agarwal: Interleukin-10 attenuates neointima proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA 102, 7251-7256 (2005) (Pubitemid 40696365)
74. Tricot, O., Z. Mallat, C. Heymes, J. Belmin, G. Leseche and A. Tedgui: Relation between endothelial cell apoptosis and blood direction in human atherosclerotic plaques. Circulation 101, 2450-2453 (2000) (Pubitemid 30366245)
75. Morse, D., L. Lin, A.M. Choi and S.W. Ryter: Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 47, 1-12 (2009)
76. Brouard, S., L.E. Otterbein, J. Anrather, E. Tobiasch, F.H. Bach, A.M. Choi and M.P. Soares: Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 192, 1015-1029 (2000)
77. Wei, Y., X.M. Liu, K.J. Peyton, H. Wang, F.K. Johnson, R.A. Johnson and W. Durante: Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 297, C907-C915 (2009)
78. Liu, X.M., G.B. Chapman, K.J. Peyton, A.I. Schafer and W. Durante: Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55, 396-405 (2002) (Pubitemid 34775290)
79. Liu, X.M., G.B. Chapman, K.J. Peyton, A.I. Schafer and W. Durante: Antiapoptotic action of carbon monoxide in cultured vascular smooth muscle cells. Exp Biol Med (Maywood) 228, 572-575 (2003) (Pubitemid 37203680)
80. Clarke, M.C., N. Figg, J.J. Maguire, A.P. Davenport, M. Goddard and T.D. Littlewood: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12, 1075-1080 (2006) (Pubitemid 44353389)
81. Chauveau, C., S. Remy, P.J. Royer, M. Hill, S. Tanguy- Royer, F.-X. Hubert, L. Tesson, R. Brion, G. Beriou, M. Gregoire, R. Josien, M.C. Cuturi and I Anegon: Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106, 1694-1702 (2005) (Pubitemid 41208583)
82. Mashreghi, M.F., R. Klemz, I.S. Knosalla, B, Gerstmayer, U. Janssen, R. Buelow, A. Jozkowicz, J. Dulak, H.D. Volk and K. Kotsch: Inhibition of dendritic cell maturation and function is independent of heme oxygenase-1 but requires the activation of STAT3. J Immunol 180, 7919-7930 (2008)
83. Park, D.J., A. Agarwal and J.F. George: Heme oxygenase-1 expression in murine dendritic cell subpopulations: effect on CD8+ dendritic cell differentiation in vivo. Am J Pathol 176, 2831-2839 (2010)
84. Kotsch, K., P.N. Martins, R. Klemz, U. Janssen, B. Gerstmeyer, A. Dernier, A. Reutzel-Selke, U. Kuckelkorn, S.G. Tullius and H.D. Volk: Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid Redox Signal 9, 2049-2063 (2007) (Pubitemid 350059022)
85. Remy, S., P. Blancou, L. Tesson, V. Tardif, R. Brion, P.J. Royer, R. Motterlini, R. Foresti, M. Painchaut, S. Pogu, M. Gregoire, J.M. Bach, I. Anegon and C. Chauveau: Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol 182, 1877-1884 (2009)
86. Liu, Y., P. Li, J. Lu, W. Xiong, J. Oger, W. Tetzlaff and M. Cynader: Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 181, 1887-1897 (2008)
87. Cheng, C., M. Noorderloos, E.D. van Deel, D. Tempel, W. den Dekker, K. Wagtmans, D.J. Duncker, M.P. Soares, J.D. Laman and H.J. Duckers: Dendritic cell function in transplantation arteriosclersosis is regulated by heme oxygenase-1. Circ Res 106, 1656-1666 (2010)
88. Pae, H.O., G.S. Ho, B.M. Choi, S.C. Chae and H.T Chung: Differential expressions of heme oxygenase-1 gene in CD25- and CD25+ subsets of human CD4+ T cells. Biochem Biophys Res Commun 306, 71-705 (2003)
89. Pae, H.O., G.S. Ho, B.M. Choi, S.C. Chae, Y.M. Kim, K.R. Chung and H.T. Chung: Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172, 4744-4751 (2004)
90. Yamashita, K., J. McDaid, R. Ollinger, T.Y. Tsui, P.O. Berberat, A. Usheva, E. Czismadia, R.N. Smith, M.P. Soares and F.H. Bach: Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac grafts. FASEB J 18, 765-767 (2004)
91. McDaid, J., K. Yamashita, A. Chora, R. Ollinger, T.B. Strom, X.C. Li, F.H. Bach and M.P. Soares: Heme oxygenase-1 modulates the alloimune response by promoting activation-induced cell death of T cells. FASEB J 19, 458-460 (2005) (Pubitemid 40316549)
92. Song, R., Z. Zhou, P.K. Kim, R.A. Shapiro, F. Liu, C. Ferran, A.M. Choi and L.E. Otterbein: Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem 279, 44327-44334 (2004) (Pubitemid 39430837)
93. Stenzel, K.H., A.L. Rubin and A. Novogrodsky: Mitogenic and co-mitogenic properties of hemin. J Immunol 127, 2469-2473 (1981) (Pubitemid 12245843)
94. Ke, B., R. Buelow, X.D. Shen, J. Milinek, F. Gao, T. Ritter, H.D. Volk, R.W. Busuttil and J.W. Kupiec-Weglinski: Heme oxgenase-1 gene therapy: a novel immunological approach in liver allograft recipients. Transplant Proc 33, 581-582 (2001) (Pubitemid 32237523)
95. Ke, B., R. Buelow, X.D. Shen, J. Melinik, F. Amersi, F. Gao, T. Ritter, H.D. Volk, R.W. Busuttil and J.W. Kupiec- Weglinski: Heme oxygenase 1 gene transfer prevents CD95/Fas lignd-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13, 1189-1199 (2002) (Pubitemid 34746699)
96. Choi, B.M., H.O. Pae, Y.R. Jeong, Y.M. Kim and H.T. Chung: Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 327, 1066-1071 (2005)
97. Zelenay, S., A. Chora, M.P. Soares and J. Demengeot: Heme oxygenase-1 is not required for mouse regulatory T-cell development and function. Int Immunol 19, 11-18 (2007) (Pubitemid 46017883)
98. George, J.F., A. Braun, T.M. Brusko, R. Joseph, S. Bolisetty, C.H. Wasserfall, M.A. Atkinson, A. Agarwal and M.H. Kapturczak: Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am J Pathol 173, 154-160 (2008) (Pubitemid 351947963)
99. Sun, J., G.K.Sukhova, P.J. Wolters, M. Yang, S. Kitamoto, P. Libby, L.A. MacFarlane, J. Mallen-St Clair and G.P. Shi: Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13, 719-724 (2007) (Pubitemid 46889760)
100. Bot. I., S.C. de Jager, A. Zernecke, K.A. Lindstedt, T. J. van Berkel, C. Weber and E.A. Biessen: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115, 2516-2525 (2007) (Pubitemid 46763225)
101. Takamiya, R., M. Murakami, M. Kajimura, N. Goda, N. Makino, Y. Takamiya, T, Yamaguchi, Y. Ishimura, N. Hozumi and M. Suematsu: Stabilization of mast cells by heme oxygenase: an anti-inflammatory role. Am J Physiol Heart Circ Physiol 283, H861-H870 (2002)
102. Yasui, Y., M. Nakamura, T. Onda, T. Uehara, S. Murata, N. Matsui, N. Fukuishi, R. Akagi, M. Suematsu and M. Akagi: Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem Biophys Res Commun 354, 485-490 (2007) (Pubitemid 46161349)
103. Semple, J.W. and J. Freedman: Platelets and innate immunity. Cell Mol Life Sci 67, 499-511 (2010)
104. Mansouri, A and C.A. Perry: Inhibition of platelet ADP and serotonin release by carbon monoxide. Experentia 40, 515-517 (1984) (Pubitemid 14096265)
105. Brune, B and V. Ullrich: Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32, 497-504 (1987) (Pubitemid 18006150)
106. Wagner, C.T., W. Durante, N. Christodoulides, J.D. Hellums and A.I. Schafer: Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100, 589-596 (1997) (Pubitemid 27340506)
107. Chlopicki, S., R. Olszanecki, E. Marcinkiewicz, M. Lomnicka and R. Motterlini: Carbon monoxide release by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovas Res 71, 393-401 (2006) (Pubitemid 43949260)
108. Morisaki, H., T. Katayama, Y. Kotake, M. Ito, M. Handa, Y. Ikeda, J. Takeda and M. Suematsu: Carbon monoxide modulates endotoxin-induced microvascular leukocyte adhesion through platelet-dependent mechanisms. Anesthesiology 97, 701-709 (2002) (Pubitemid 34977331)
109. Peng, L., L. Mundada,J.M. Stomel J.J. Liu, J. Sun,Y.S Yet and W.P. Fay: Induction of heme oxygenase- 1 expression inhibits platelet-dependent thrombosis. Antioxid Redox Signal 6, 729-735 (2004). (Pubitemid 38890790)
110. Lindenblatt, N., R. Bordel, W. Schareck, M.D. Menger and B. Vollmar: Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol 24, 1-6 (2004)
111. True, A.L., M. Olive, M. Boehm, H. San, R.J. Westrick, N. Raghavachari, X. Xu, E.G. Lynn, M.N. Sack, P.J. Munson,M.T. Gladwin and E.G. Nabel: Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101, 893-901 (2007) (Pubitemid 350287176)
112. Tracz, M.J., J.P. Juncos, J.P. Grande, A.J. Croatt, A.W. Ackerman,Z.S Katusic and K.A. Nath: Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosis. Am J Pathol 173, 1882-1890 (2008)
113. Chen, B., L. Guo, C. Fan, S. Bolisetty, R. Joseph, M.W. Wright, A. Agarwal and J.F. George: Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am J Pathol 175, 422-429 (2009)
114. Morimoto, Y., W. Durante, D.G. Lancaster, J. Klattenhoff and F. K. Tittel: Real-time measurements of endogenous CO production from vascular cells using an ultrasensitive laser sensor. Am J Physiol Heart Circ Physiol 280, H483-H488 (2001)
115. Rank, J.M., J.G. Straka, M.K. Weimer, I. Boissenmaier, B.L. Taddeini BL and J.R. Bloomer: Hematin therapy in late onset congenital erythropoietic porphyria. Br J Haematol 75, 617-618 (1990) (Pubitemid 20271499)
116. Dellon, E.S., Z.M. Szczepiorkowski, W.H. Dzik, F. Graeme-Cook, A. Ades, J.R. Bloomer, A.B. Cosimi and R.T. Chung: Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 73, 911-915 (2002) (Pubitemid 34252354)
117. Bharucha, A.E., A. Kulkarni, K.M. Choi, M. Camilleri, M. Lempke, G.J. Brunn, S.J. Gibbons, A.R. Zinsmeister and G. Farrugia: First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther 87, 187-190 (2010)
118. Ogborne, R.M., S.A. Rushworth, C.A. Charalambos and M.A. O'Connell: Haem oxygenase-1: a target for dietary antioxidants. Biochem Soc Trans 32, 1003-1005 (2004) (Pubitemid 39655527)
119. Erdmann, K., N. Grosser and H. Schroder: Lmethionine reduces oxidant stress in endothelial cells: role of heme oxygenase-1, ferritin, and nitric oxide. AAPS J 7:E195-E200 (2005) (Pubitemid 41554289)
120. Grosser, N., S. Oberle, G. Berndt, K. Erdmann, A. Hemmerle and H. Schroder: Antioxidant action of Lalanine: heme oxygenase-1 and ferritin as possible mediators. Biochem Biophys Res Commun 314, 351-355 (2004) (Pubitemid 38084723)
121. Uehara, K., T. Takahashi, H. Fujii, H. Shimizu, E. Omori, M. Matsumi, M. Yokoyama, K. Morita, T. Akagi and S. Sassa: The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med 33, 381-390 (2005) (Pubitemid 40216553)
122. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389 (1994)
123. Ridker, P.M., C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer and E. Braunwald: Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352, 20-28 (2005)
124. Grosser, N., A. Hemmerle, G. Berndt, K. Erdmann, U. Hinkelmann, S. Schurger, N. Wijayanti, S. Immenschuh and H. Schroder: The antioxidant defense protein heme oxygenase-1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37, 2061-2071 (2004)
125. Grosser, N., K. Erdmann, A. Hemmerle, G. Berndt, U. Hinkelmann, G. Smith and H. Schroder: Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 325, 871-876 (2004) (Pubitemid 39487953)
126. Lee, T.S., C.C. Chang, Y. Zhu and J.Y. Shyy: Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110, 1296-1302 (2004). (Pubitemid 39202348)
127. Hsu, M., L. Muchova, I. Moriaka, J.R. Wong, H. Schroder and D.K. Stevenson: Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343, 738-744 (2006)
128. Ali, F., M. Zakkar, K. Karu, E.A. Lidington, S.S. Hamdulay, J.J. Boyle, M. Zloh, A. Bauer, D.O. Haskard, P.C. Evans and J.C. Mason: Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 284, 18882-18892 (2009)
129. Loboda, A., A. Jazwa, A. Jozkowicz, J. Dorosz, J. Balla, G. Molema and J. Dulak: Atorvastatin prevents hypoxiainduced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis 187, 26-30 (2006) (Pubitemid 43833360)
130. Sawayama, Y., C. Shimizu, N. Maeda, M. Tatsukawa, N. Kinukawa, S. Koyanagi, S. Kashiwagi and J. Hayashi: Effect of probucol and pravastin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 39, 610-616 (2002) (Pubitemid 34158156)
131. Witting, P.K., K. Pettersson, J. Letters and R. Stocker: Site-specific anti-atherogenic effect of probucol in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 20, e26-e33 (2000)
132. Deng, Y.M., B.J. Wu, P.K. Witting and R. Stocker: Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110, 1855-1860 (2004) (Pubitemid 39299229)
133. Wu, B.J., K. Kathir, P.K. Witting, K. Beck, K. Choy, C Li, K.D. Croft, T.A. Mori, D. Tanous, M.R. Adams, A.K. Lau and R. Stocker: Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203, 1117-1127 (2006)
134. Grosser, N., A. Abate, S. Oberle, H.J. Vreman, P.A. Dennery, J.C Becker, T. Pohle, D.S. Seidman and H. Schroder. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308, 956-960 (2003) (Pubitemid 36976552)
135. Visner, G.A., F. Lu, H. Zhou, J. Liu, K. Kazemfar and A. Agarwal: Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107,
136. Zhou, H., H. Liu, S.L. Porvasnik, N. Terada, A. Agarwal, Y. Cheng and G.A. Visner: Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab Invest 86, 62-71 (2006) (Pubitemid 43250969)
137. Choi, B.M., Y.M. Kim, Y.R. Jeong, H.O. Pae, C.E. Song, J.E. Park, Y.K. Ahn and H.T. Chung: Induction of heme oxygenase-1 is involved in the antiproliferative effects of paclitaxel in rat vascular smooth muscle cells. Biochem Biophys Res Commun 25, 39-47 (2004)
138. Liu, X.M., G.B. Chapman, H. Wang, and W. Durante: Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 105, 79-84 (2002) (Pubitemid 34049146)
139. Suttner, D.M and P.A. Dennery: Reversal of HO-1 related cytoprotection with increased expression due to reactive iron. FASEB J 13, 1800-1809 (1999) (Pubitemid 29473342)
140. Exner, M., E. Minar, O. Wagner and M. Schillinger: The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37, 1097-1104 (2004) (Pubitemid 39296737)
141. Duckers, H.J., M. Boehm, A.L. True, S.-F. Yet, J.L. Park, R.C. Webb, M.-E. Lee, G.J. Nabel and E.G. Nabel: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7, 693-698 (2001) (Pubitemid 32588025)
142. Tulis, D.A, W. Durante, X. Liu, A.J. Evan, K.J Peyton and A.I. Schafer: Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104, 2710-2715 (2001) (Pubitemid 33108139)
143. Abraham, N.G., A. Asija, G. Drummond and S. Peterson: Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 7, 89-108 (2007) (Pubitemid 46681767)
144. Otterbein, L.E., B.S. Zuckerbraun, M. Haga, F. Liu, R. Song, A. Usheva, C. Stachulak, N. Bodyak, R. Neil Smith, E. Czismadia, S. Tyagi, Y. Akamatsu, R.J. Flavell, T.R. Billiar, E. Tzeng, F.H. Bach, A.M.K. Choi and M.P. Soares: Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9, 183-190 (2003) (Pubitemid 36227720)
145. Moore, B.A., M. Overhaus, J. Whitcomb, E. Ifedigbo, A.M. Choi, L.E. Otterbein and A.J. Bauer: Brief inhalation of low-dose carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg. Res 138, 121-127 (2007) (Pubitemid 46227462)
146. Zuckerbraun, B.S., B.Y. Chin, B. Wegiel, T.R. Billiar, E. Czsimadia, J. Rao, L. Shimoda, E. Ifedigbo, S. Kanno, and L.E. Otterbein: Carbon monoxide reverses established pulmonary hypertension. J Exp Med 203, 2109-2119 (2006) (Pubitemid 44352232)
147. Ott, M.C., J. R. Scott, A. Bihari, A. Badhwar, L.E. Otterbein, D.K. Gray, K.A. Harris and R.F. Potter : Inhalation of carbon monoxide prevents liver injury and inflammation following hindlimb ischemia/reperfusion. FASEB J 19, 106-108 (2005) (Pubitemid 40069933)
148. Carbon monoxide now orphan drug for transplantation. Inpharma 1, 21 (2008)
149. Mayr, F.B., S. Spiel, J. Leitner, C. Marsik, P. Germann, R. Ullrich, O. Wagne and B. Jilma: Effect of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 171, 354-360 (2005) (Pubitemid 40223403)
150. Bathoorn, E., D.-J. Slebos, D.S. Postma, G.H. Koeter, A.J.M. van Oosterhout, M. van der Toorn, H.M. Boezen and H.A.M. Kerstjens: Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 30, 1131-1137 (2007) (Pubitemid 351194760)
151. Tulis, D.A., A.N. Keswani, K.J. Peyton, H. Wang, A.I. Schafer and W. Durante. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol (Noisy-le-grand) 51, 441-446 (2005) (Pubitemid 41596300)
152. Vera, T., J.R. Henegar, H.A. Drummond, J.M. Rimoldi and D.E. Stec: Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 16, 950-958 (2005) (Pubitemid 41710305)
153. Foresti, R., C. Shurey, T. Ansari, P. Sibbons, B.E. Mann, T.R. Johnson, C.J. Green and R. Motterlini: Reviewing the use of carbon monoxide-releasing molecules (CO-RMs) in biology: implications in endotoxin-mediated vascular dysfunction. Cell Mol Biol (Noisy-le-grand) 51, 409-423 (2005) (Pubitemid 41596319)
154. Hyvelin, J.M., B. Maurel, R. Uzbekov, R. Motterlini and P. Lermusiaux: Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme oxygenase-1. J Vasc Res 51, 417-428 (2010)
155. Ollinger, R., M. Bilban, A. Erat, A. Froio, J. McDaid, S. Tyagi, E. Csizmadia, A.V. Graca-Souza, A. Liloia, M.P. Soares, L.E. Otterbein, A. Usheva, K. Yamashita and F.H. Bach: Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112, 1030-1039 (2005) (Pubitemid 41170272)
156. Nakao, A., N. Murase, C. Ho, B. Toyokawa, T.R. Billiar and S. Kanno: Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 112, 587-591 (2005) (Pubitemid 41060800)
157. Schwertner, H.A., W.G. Jackson and G. Tolan: Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40, 18-23 (1994) (Pubitemid 24050206)
158. Perlstein, T.S., R.L. Pande, J.A. Beckman and M.A. Creager: Serum total bilirubin level and prevalent lower extremity peripheral artery disease. Arterioscler Thromb Vasc Biol 28, 166-172 (2008)